Creager MD, M.A.; Anand, S.S.
February 2001
Vascular Medicine;2001, Vol. 6 Issue 1, p1
Academic Journal


Related Articles

  • "Treatment of Small Vessel Disease With the Paclitaxel Drug-Eluting Balloon" Is the Target Lesion the Culprit One? Blendea, Ciprian; Benedek, Imre; Chiţu, Monica // Journal of Interventional Cardiology;Dec2015, Vol. 28 Issue 6, p614 

    A letter to the editor is presented in response to the article "'Treatment of Small Vessel Disease With the Paclitaxel Drug-Eluting Balloon: 6-Month Angiographic and 1-Year Clinical Outcomes of the Spanish Multicenter Registry" by B. Vaquerizo et al. in a 2015 issue.

  • Conference Calendar.  // Journal of Vascular Research;2010, Vol. 47 Issue 4, p367 

    A calendar of events related to vascular research from June to September 2010 is presented which includes Molecular Mechanisms in Lymphatic Function and Disease conference on June 13-18, 2010, 16th International Vascular Biology Meeting on June 20-24, 2010, and the Multidisciplinary European...

  • Assessment of Pial Branches Using 7-Tesla MRI in Cerebral Arterial Disease. Song, H.-S.; Kang, C.-K.; Kim, J. S.; Park, C.-A.; Kim, Y.-B.; Lee, D. H.; Kang, D.-W.; Kwon, S. U.; Cho, Z.-H. // Cerebrovascular Diseases;Mar2010, Vol. 29 Issue 4, p410 

    The article presents a case study of a 21-year-old man who has a history of transient left limb weakness. Results of the magnetic resonance imaging (MRI) of his brain revealed ischemic lesion at the right frontal lobe and old cystic lesion at his right basal ganglia. Moreover, he was diagnosed...

  • BioTime's Subsidiary ReCyte Therapeutics Inc. Provides Update on Preclinical Development of Vascular Progenitors for the Treatment of Age-Related Vascular Disease.  // Biomedical Market Newsletter;4/28/2012, Vol. 21, p1 

    The article offers information on presentations to be given by BioTime Inc.'s subsidiary corporation ReCyte Therapeutics Inc. in which the company's executives will discuss the preclinical developments of their technologies used for treatment against age-related vascular diseases.

  • Enhanced mRNA expression of plasminogen activator inhibitor-1 in livedoid vasculopathy lesions. Agirbasli, Mehmet; Göktay, Fatih; Peker, Irem; Gunes, Pembegul; Aker, Fugen Vardar; Akkiprik, Mustafa // Cardiovascular Therapeutics;Jun2017, Vol. 35 Issue 3, pn/a 

    Aim Thrombosis and inflammation play an important role in pathophysiology of livedoid vasculopathy ( LV). Plasminogen activator inhibitor-1 ( PAI-1) is the main physiological inhibitor of fibrinolysis and is a pivotal modulator in a broad range of biological processes. Method The study specimens...

  • Combination Therapy of Nifedipine and Sulphonylureas Exhibits a Mutual Antagonistic Effect on the Endothelial Cell Dysfunction Induced by Hyperglycemia Linked to Vascular Disease. Wang, Li-Ping; Jiang, Yu; Yang, Hong; Peng, Cheng; Zhang, Chuan; Tao, Xia; Xie, He-Hui // Cellular Physiology & Biochemistry (Karger AG);Jun2016, Vol. 38 Issue 6, p2337 

    Background/Aims: By inducing severe endothelial impairment, hypertension and diabetes are two leading causes of morbidity and mortality. Hypertensive patients with concomitant diabetes must take both antihypertensive and hypoglycaemic medications, for which there is a lack of experimental and...

  • Assessment of Feasibility of Endovascular Treatment of Ruptured Intracranial Aneurysms with 16-Detector Row CT Angiography. van der Jagt, Mathieu; Flach, H. Zwenneke; Tanghe, Hervé L. J.; Bakker, Stef L. M.; Hunink, M. G. Myriam; Koudstaal, Peter J.; van der Lugt, Aad // Cerebrovascular Diseases;Nov2008, Vol. 26 Issue 5, p482 

    Background: It is unclear whether 16-detector row CT angiography (CTA) can replace digital subtraction angiography (DSA) to assess the feasibility of endovascular treatment (EVT) in the acute phase after aneurysmal subarachnoid hemorrhage. Methods: We studied 80 consecutive patients with...

  • Effect of On-Admission Antiplatelet Treatment on Patients with Cerebral Hemorrhage. Caso, Valeria; Paciaroni, Maurizio; Venti, Michele; Alberti, Andrea; Palmerini, Francesco; Milia, Paolo; Billeci, Antonia M. R.; Silvestrelli, Giorgio; Biagini, Sergio; Agnelli, Giancarlo // Cerebrovascular Diseases;2007, Vol. 24 Issue 2/3, p215 

    Background: Antiplatelet treatment remains the first choice for primary and secondary prevention of vascular diseases; even so, expected benefits may be offset by risk of bleeding, particularly cerebral hemorrhage. The aim of this study was to assess the influence of antiplatelet treatment on...

  • Effect of Angiotensin-(1-7) on Aortic Response, TNF-α, IL-1β and Receptor for Advanced Glycation Endproduct in Rat's Adjuvant-Induced Arthritis. Açikalin, Öznur; Bölükbaşi Hatip, Funda F.; Tan, Ruyal F.; Hatip-al-Khatib, Izzettin // Pharmacology;3/15/2016, Vol. 97 Issue 5/6, p207 

    Altered vascular reactivity due to endothelial dysfunction, consequent to vascular damage, is observed in rheumatoid arthritis. We investigated the effect of angiotensin (Ang)-(1- 7) on vasculature changes in arthritis induced by complete Freund's adjuvant in male Wistar rats. Arthritis...

  • One-Year Outcome of Small-Vessel Disease Treated with Sirolimus-Eluting Stents: A Subgroup Analysis of the e-SELECT Registry. GAO, RUNLIN; ABIZAID, ALEXANDRE; BANNING, ADRIAN; BARTORELLI, ANTONIO L.; DŽAVÍK, VLADIMÍR; ELLIS, STEPHEN; JEONG, MYUNG HO; LEGRAND, VICTOR; SPAULDING, CHRISTIAN; URBAN, PHILIP // Journal of Interventional Cardiology;Apr2013, Vol. 26 Issue 2, p163 

    Objectives To investigate the characteristics and one-year outcomes following sirolimus-eluting CYPHER Select Plus stent (SES) implantation in small (SmVD) and non-small vessel disease (NSmVD) in the international e-SELECT registry. Background Large-scale registry data are lacking on DES...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics